Natalist
Consumer reproductive-health brand offering science-backed fertility, pregnancy, and postpartum products, acquired by Everly Health in 2021.
What They Do
Natalist sells direct-to-consumer fertility, pregnancy, and postpartum essentials, alongside educational content designed to make reproductive health feel less clinical and less confusing. The brand's core wedge is not care delivery or provider workflow; it is trusted consumer products, content, and retail distribution for people trying to conceive, pregnant, or newly postpartum. By the time of its acquisition, Natalist had expanded from e-commerce into thousands of retail doors, which made it more of a scaled reproductive-health consumer brand than a niche startup storefront. That makes Natalist more adjacent than central to the clinical-company universe, but still strategically relevant as a Rock Health-backed family-building brand with strong category signaling.
Competitive Position
Natalist competes more with modern consumer fertility and pregnancy brands than with virtual clinics such as maven-clinic or pomelo-care. Its differentiation has been design-forward, evidence-backed packaging and content for reproductive health, plus retail accessibility after launch. In our taxonomy it is best understood as a family-building and reproductive-health brand adjacent to care delivery, not a core maternal-care infrastructure company.
Funding Rounds
No funding rounds on record for this company.